Invest Well in AbbVie Stock: Products, Dividend, Financial Statements, and More
When making long-term investments to ensure stability through diversified investments, it is recommended to prioritize ETFs that include AbbVie stocks. However, there might still be individuals who wish to invest directly in AbbVie stocks. Shall we also explore a value investing approach to assess whether AbbVie's performance will grow in the long term?
Q. What products and services does AbbVie provide?
AbbVie is a biopharmaceutical company that develops and sells pharmaceutical products mainly related to immune and chronic diseases.
- AbbVie focuses on the development of pharmaceuticals centered on immune diseases, neurological diseases, and liver diseases.
Q. What is AbbVie's competitive advantage?
- The pharmaceutical industry is constantly changing, so it is important for companies to continuously innovate and respond to changes.
Q. Is AbbVie's executive CEO honest and competent?
- Richard A. Gonzalez has been the founding CEO of AbbVie since 2013.
- He served as President and COO of Abbott in 2007.
- He has worked at Abbott, a pharmaceutical company, for 30 years.
Q. Is AbbVie's financial statements healthy?
Net Profit Margin
- AbbVie has earned an annual net profit equivalent to 1.60% of the current stock price.
- Thenet profit has been decreasingat an annual rate of -3.15% over the past 5 years, so it's something to be cautious about.
Total Debt
- The debt is 1261.88% of the annual net profit.
- It would take about 13 years for the company to repay all of its debt.
- The net profit is decreasing, so AbbVie should be careful about managing the debt.
Dividend
- AbbVie offers a 3.65% annual dividend.
- Over the past 5 years, the annual average dividend has grown by 7.69%.
- Dividends are growing, which is good.
Share Buyback
- Apple recently repurchased its own shares equivalent to 0.66% of the stock price in the past year.
- The recent share buyback amount is 134.67% higher than the 3-year average.
Q. What is AbbVie's stock performance like?
- This year's total return is 13.88%.
- 5-year mean total return is 21.45%.
Q. When is a good time to buy and sell AbbVie?
If AbbVie is healthy and growing, it will rise in the long run, so it is good to buy in installments even if you think the current stock price is a bit high. On the other hand, if you think that AbbVie is no longer healthy in the long run, you can consider selling.
PER
- Current: 62.50
- 5Y Avg: 35.49
- The current value is higher than the average, so be careful when buying. However, purchasing can be considered only if you judge that the company will sustain high long-term growth.
Price/Sale Ratio
- Current: 5.53
- 5Y Avg: 4.50
- Current value is higher than average so be careful when buying. However, purchasing can be considered only if you judge that the company will sustain high long-term growth.